ClearPoint Neuro, Inc. — Director's Dealing 2022

Oct 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2022-10-10

Reporting Person: SABRA MAZIN (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-10	Common Stock	A	46000	—	Acquired	46900	Direct

Footnotes

F1: The shares are restricted stock and vest as follows: (i) one-third (1/3rd) on the first anniversary of the grant date; (ii) one-third (1/3rd) on the second anniversary of the grant date; and (iii) one-third (1/3rd) on the third anniversary of the grant date.